Status:
RECRUITING
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
Ministry of Higher Education, Science and Technology, Solvenia
Conditions:
Antiphospholipid Syndrome
Eligibility:
All Genders
1-18 years
Brief Summary
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Eligibility Criteria
Inclusion
- 18 years of age or younger at the onset of disease
- Presence of Vascular Thrombosis
- UC Davis patient
- Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma
Exclusion
- Infants born to mothers with APS
- Infants with congenital thrombophilia
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2040
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00616317
Start Date
September 1 2006
End Date
January 1 2040
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Medical Center
Sacramento, California, United States, 95817